Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model

Antiviral Research
H S LiJohn M Nicholls

Abstract

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has emerged as a coronavirus infection of humans in the past 5 years. Though confined to certain geographical regions of the world, infection has been associated with a case fatality rate of 35%, and this mortality may be higher in ventilated patients. As there are few readily available animal models that accurately mimic human disease, it has been a challenge to ethically determine what optimum treatment strategies can be used for this disease. We used in-vitro and human ex-vivo explant cultures to investigate the effect of two immunomodulatory agents, interferon alpha and cyclosporine, singly and in combination, on MERS-CoV replication. In both culture systems the combined treatment was more effective than either agent used alone in reducing MERS-CoV replication. PCR SuperArray analysis showed that the reduction of virus replication was associated with a greater induction of interferon stimulated genes. As these therapeutic agents are already licensed for clinical use, it may be relevant to investigate their use for therapy of human MERS-CoV infection.

Associated Clinical Trials

Citations

Jul 10, 2020·Critical Reviews in Clinical Laboratory Sciences·Marco CiottiSergio Bernardini
Jul 9, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Quirino LaiJan Lerut
Jul 8, 2020·Viruses·Jennifer SantosArwen B L Declan
May 30, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sean McConachieLama Hsaiky
Aug 11, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nadia Nicholine PoulsenMartin Blomberg Jensen
Aug 1, 2020·The European Respiratory Journal·Adam Molyvdas, Sadis Matalon
Aug 13, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Rasmus RiviniusPhilip W Raake
Aug 25, 2020·Current Pharmacology Reports·Linzi FanChunjuan Yang
Sep 29, 2020·Frontiers in Pharmacology·Tessa S SchootRob J van Marum
Apr 29, 2020·Indian Journal of Pediatrics·Shipin FengRong Zhu
Jul 4, 2020·The European Respiratory Journal·Lucie SauerheringChristin Peteranderl
Jun 6, 2020·Journal of Biomedical Science·Feng-Yee ChangHuey-Kang Sytwu
Aug 25, 2020·Der Nephrologe·H RohnO Witzke
May 21, 2020·International Journal of Molecular Sciences·Valentino ClementeMartina Bazzaro
Dec 20, 2018·Viruses·Ruiying LiangFei Yu
Jun 27, 2020·Clinical Transplantation·Florian BöschMarkus O Guba
Nov 12, 2020·Der Gastroenterologe : Zeitschrift Für Gastroenterologie Und Hepatologie·H RohnO Witzke
May 5, 2021·Advanced Biology·Sarah L BarronRóisín M Owens
May 22, 2021·Frontiers in Pharmacology·Xinlei Li, Tao Peng
May 25, 2021·Clinical Transplantation·Rafaela Vale de Miranda SorianoHui Tzu Lin-Wang
Jul 24, 2020·Clinical Kidney Journal·Luis D'MarcoJosé Luis Gorriz

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
PCR

Software Mentioned

RT 2 Profiler PCR Array Data Analysis Template
ImageJ

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.